These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29899212)

  • 61. Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects.
    Eckburg PB; Lister T; Walpole S; Keutzer T; Utley L; Tomayko J; Kopp E; Farinola N; Coleman S
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262767
    [TBL] [Abstract][Full Text] [Related]  

  • 62. No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.
    Purkins L; Wood N; Kleinermans D; Love ER
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):62-8. PubMed ID: 14616416
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.
    Burdette SD; Trotman R
    Clin Infect Dis; 2015 Oct; 61(8):1315-21. PubMed ID: 26105167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease.
    Hey JA; Yu JY; Versavel M; Abushakra S; Kocis P; Power A; Kaplan PL; Amedio J; Tolar M
    Clin Pharmacokinet; 2018 Mar; 57(3):315-333. PubMed ID: 29063518
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of coadministration of metformin with mirogabalin: Results from a phase 1, randomized, open-label, drug-drug interaction study
.
    Dow J; Currie A; He L; Zaidi F; Zahir H
    Int J Clin Pharmacol Ther; 2018 Oct; 56(10):451-458. PubMed ID: 30049303
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
    Vaughan D; Speed J; Medve R; Andrews JS
    Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of Telavancin on the pharmacokinetics of the cytochrome P450 3A probe substrate midazolam: a randomized, double-blind, crossover study in healthy subjects.
    Wong SL; Goldberg MR; Ballow CH; Kitt MM; Barriere SL
    Pharmacotherapy; 2010 Feb; 30(2):136-43. PubMed ID: 20099988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tedizolid Phosphate: a Next-Generation Oxazolidinone.
    Rybak JM; Roberts K
    Infect Dis Ther; 2015 Feb; 4(1):1-14. PubMed ID: 25708156
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
    Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
    Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extended-release tablets in healthy volunteers.
    Nomeir AA; Mojaverian P; Kosoglou T; Affrime MB; Nezamis J; Rodwanski E; Lin CC; Cayen MN
    J Clin Pharmacol; 1996 Oct; 36(10):923-30. PubMed ID: 8930779
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety, tolerability and pharmacokinetics of trimebutine 3-thiocarbamoylbenzenesulfonate (GIC-1001) in a randomized phase I integrated design study: single and multiple ascending doses and effect of food in healthy volunteers.
    Paquette JM; Rufiange M; Iovu Niculita M; Massicotte J; Lefebvre M; Colin P; Telmat A; Ranger M
    Clin Ther; 2014 Nov; 36(11):1650-64. PubMed ID: 25224876
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis.
    Srivastava S; Deshpande D; Nuermberger E; Lee PS; Cirrincione K; Dheda K; Gumbo T
    Clin Infect Dis; 2018 Nov; 67(suppl_3):S336-S341. PubMed ID: 30496463
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
    Rybak JM; Marx K; Martin CA
    Pharmacotherapy; 2014 Nov; 34(11):1198-208. PubMed ID: 25266820
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of the human endotoxin challenge on tedizolid tissue penetration.
    Jorda A; Wulkersdorfer B; Schoergenhofer C; Matzneller P; Al Jalali V; Bauer M; Wölfl-Duchek M; Lackner E; Dorn C; Jilma B; Zeitlinger M
    Br J Clin Pharmacol; 2023 Jan; 89(1):416-420. PubMed ID: 36223278
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs.
    Benavent E; Morata L; Escrihuela-Vidal F; Reynaga EA; Soldevila L; Albiach L; Pedro-Botet ML; Padullés A; Soriano A; Murillo O
    Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33429902
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction study.
    Spyker DA; Cassella JV; Stoltz RR; Yeung PP
    Pharmacol Res Perspect; 2015 Dec; 3(6):e00194. PubMed ID: 27022468
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tedizolid phosphate (sivextro): a second-generation oxazolidinone to treat acute bacterial skin and skin structure infections.
    Wong E; Rab S
    P T; 2014 Aug; 39(8):555-79. PubMed ID: 25136252
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success.
    Morrisette T; Molina KC; Da Silva B; Mueller SW; Damioli L; Krsak M; Miller MA; Fish DN
    Open Forum Infect Dis; 2022 Jun; 9(6):ofac028. PubMed ID: 35615295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.